OVERVIEW
The market for molecular diagnostics is expected to reach USD 12.2 billion by 2024, growing over the forecast period at a CAGR of 8%. The rise in this market is driven primarily by the high prevalence of infectious diseases and various types of cancers, growing awareness and acceptance of personalized medicine and companion diagnostics, development in the market for biomarker detection, and advances in molecular techniques.
TABLE OF CONTENT
1 Global Molecular Diagnostics MarketÂ
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Molecular Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Molecular Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Molecular Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Molecular Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Molecular Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Molecular Diagnostics Market – By Product (Market Size – & million/billion)
8.1 Reagents & Kits
8.2 Instruments
9 Global Molecular Diagnostics Market – By Technology
9.1 In Situ Hybridization
9.2 Chips and Microarrays
9.3 Mass Spectrometry (MS)
9.4 Sequencing
9.5 PCR
9.6 Other
10 Global Molecular Diagnostics Market – By Application
10.1 Infectious Disease
10.2 Oncology
10.3 Pharmacogenomics
10.4 Microbiology
10.5 Genetic Disease Screening
10.6 Human Leukocyte Antigen Typing
10.7 Others
11 Global Molecular Diagnostics Market – By End-User
11.1 Hospital
11.2 Laboratories
11.3 Other
12 Global Molecular Diagnostics Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Molecular Diagnostics Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Molecular Diagnostics Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Agilent Technologies
14.3 Abbott Laboratories
14.4 Illumina
14.5 Danaher Corporation
14.6 Grifols
14.7 Becton, Dickinson and Company
14.8 Biomérieux Sa
14.9 Diasorin
14.10 Hologic
14.11 Qiagen
14.12 Company 11 & more
15 Global Molecular Diagnostics Market – Appendix
15.1 Sources
15.2 Abbreviations